PHARMACEUTICAL PRODUCT DEVELOPMENT INC
10-Q, EX-27, 2000-08-11
COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
Previous: PHARMACEUTICAL PRODUCT DEVELOPMENT INC, 10-Q, EX-10.147, 2000-08-11
Next: MUNICIPAL MORTGAGE & EQUITY LLC, 10-Q, 2000-08-11



<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
This schedule contains summary financial information extracted from the
Pharmaceutical Product Development Inc. Consolidated Balance Sheet and Statement
of Operations included within this Form 10-Q and is qualified in its entirety by
reference to such financial statements.
</LEGEND>
<MULTIPLIER> 1,000

<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          DEC-31-2000
<PERIOD-START>                             JAN-01-2000
<PERIOD-END>                               JUN-30-2000
<CASH>                                          62,791
<SECURITIES>                                         0
<RECEIVABLES>                                  114,623
<ALLOWANCES>                                       925
<INVENTORY>                                          0
<CURRENT-ASSETS>                               197,096
<PP&E>                                         118,944
<DEPRECIATION>                                  61,175
<TOTAL-ASSETS>                                 298,507
<CURRENT-LIABILITIES>                           86,930
<BONDS>                                              0
                                0
                                          0
<COMMON>                                         2,492
<OTHER-SE>                                     205,989
<TOTAL-LIABILITY-AND-EQUITY>                   298,507
<SALES>                                              0
<TOTAL-REVENUES>                               165,810
<CGS>                                                0
<TOTAL-COSTS>                                   85,814
<OTHER-EXPENSES>                                61,429
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                 444
<INCOME-PRETAX>                                 21,595
<INCOME-TAX>                                     8,028
<INCOME-CONTINUING>                             13,567
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                    13,567
<EPS-BASIC>                                       0.55
<EPS-DILUTED>                                     0.54


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission